Market Cap: 37.3446B; Large Cap
P/E Ratio: 187.58; Fwd: 56.82
EPS (TTM): $2.47
Div. Yield: N/A

AX

AXONNASDAQ— Axon Enterprise Inc. Price & Analysis

Axon Enterprise Inc.

INDUSTRIALS — AEROSPACE & DEFENSE

$464.83

+$20.10+4.52%

Market Cap: 37.3446B; Large Cap
P/E Ratio: 187.58; Fwd: 56.82
EPS (TTM): $2.47
Div. Yield: N/A

Technical Summary

RSI (14)57.80Neutral

SMA (50)$420.37Bullish

SMA (200)$537.25Bearish

MACD5.3381Bearish

Bollinger$404.24 – $504.76Mid

Stochastic51.76Neutral

Theo Outlook

Axon Enterprise trades at a premium valuation with a trailing P/E of 183.51 and forward P/E of 55.25 on a $36.83 billion market cap, supported by TTM EPS of $2.49 and 33.7% year-over-year revenue growth to $2.98 billion. The stock reflects strong investor confidence in its high-margin software and hardware ecosystem despite the elevated multiple relative to the broader industrials sector. Bullish sentiment is reinforced by 89.8% quarterly earnings growth and robust institutional ownership at 88.7%.

Key catalysts include continued adoption of Axon's TASER conducted energy weapons and cloud-based evidence management platforms, with recent product expansions into body-worn cameras and AI-driven analytics driving international market penetration. Earnings momentum remains positive, evidenced by the latest quarter's 33.7% revenue increase and analyst consensus target of $662.04, implying significant upside from current levels. Growth is further supported by recurring subscription revenue from Axon Evidence and Fleet services.

Risks center on regulatory scrutiny of conducted energy devices, potential competition from emerging non-lethal alternatives, and macroeconomic headwinds such as municipal budget constraints that could slow public-sector spending. Mitigations include Axon's strong balance sheet, diversified revenue streams across hardware and software, and ongoing R&D investment to maintain technological leadership. The company also benefits from high barriers to entry in the public safety market. Analysis generated by HeyTheo AI based on SEC filings, earnings transcripts, and market data.

Theo Outlook

Axon Enterprise trades at a premium valuation with a trailing P/E of 183.51 and forward P/E of 55.25 on a $36.83 billion market cap, supported by TTM EPS of $2.49 and 33.7% year-over-year revenue growth to $2.98 billion. The stock reflects strong investor confidence in its high-margin software and hardware ecosystem despite the elevated multiple relative to the broader industrials sector. Bullish sentiment is reinforced by 89.8% quarterly earnings growth and robust institutional ownership at 88.7%.

Key catalysts include continued adoption of Axon's TASER conducted energy weapons and cloud-based evidence management platforms, with recent product expansions into body-worn cameras and AI-driven analytics driving international market penetration. Earnings momentum remains positive, evidenced by the latest quarter's 33.7% revenue increase and analyst consensus target of $662.04, implying significant upside from current levels. Growth is further supported by recurring subscription revenue from Axon Evidence and Fleet services.

Risks center on regulatory scrutiny of conducted energy devices, potential competition from emerging non-lethal alternatives, and macroeconomic headwinds such as municipal budget constraints that could slow public-sector spending. Mitigations include Axon's strong balance sheet, diversified revenue streams across hardware and software, and ongoing R&D investment to maintain technological leadership. The company also benefits from high barriers to entry in the public safety market. Analysis generated by HeyTheo AI based on SEC filings, earnings transcripts, and market data.

Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (DEC) under the TASER brand name in the United States and internationally. The company is headquartered in Scottsdale, Arizona.

Fundamental Snapshot

Revenue: 2.9832B
EBITDA: 102.861M
Gross Profit: 1.7739B
Operating Margin: 3.8%
Profit Margin: 6.9%
ROE: 6.8%
Book Value: $43.86
Beta: 1.422
52-Wk High: $885.92
52-Wk Low: $339.01
Avg Volume: 1.4729M
PEG Ratio: 1.645

Frequently Asked Questions

What is Axon Enterprise's core business model?

Axon Enterprise develops and sells conducted energy weapons under the TASER brand along with body cameras, cloud software, and evidence management solutions primarily to law enforcement and military customers. The model combines one-time hardware sales with high-margin recurring subscription revenue from its Axon Evidence platform, which accounted for a growing share of the $2.98 billion TTM revenue.

Where does Axon generate most of its revenue?

The majority of revenue comes from the United States through sales of TASER devices, body-worn cameras, and software subscriptions to police departments and other public safety agencies. International markets are expanding, but domestic public-sector contracts remain the primary driver, supported by 33.7% quarterly revenue growth.

What are Axon's main competitive advantages?

Trading Data

Open: $445.04
Previous Close: $444.73
Day Range: $440 – $477.17
Volume: 1.482M
Shares Outstanding: 80.602M
Analyst Target: $662.04

Related Assets

HO

HON

Honeywell International Inc

Get Deeper Analysis

Ask Theo anything about AXON — earnings, valuation, technicals, or portfolio fit.

Try HeyTheo Free

Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (DEC) under the TASER brand name in the United States and internationally. The company is headquartered in Scottsdale, Arizona.

Fundamental Snapshot

Revenue: 2.9832B
EBITDA: 102.861M
Gross Profit: 1.7739B
Operating Margin: 3.8%
Profit Margin: 6.9%
ROE: 6.8%
Book Value: $43.86
Beta: 1.422
52-Wk High: $885.92
52-Wk Low: $339.01
Avg Volume: 1.4729M
PEG Ratio: 1.645

Frequently Asked Questions

What is Axon Enterprise's core business model?

Axon Enterprise develops and sells conducted energy weapons under the TASER brand along with body cameras, cloud software, and evidence management solutions primarily to law enforcement and military customers. The model combines one-time hardware sales with high-margin recurring subscription revenue from its Axon Evidence platform, which accounted for a growing share of the $2.98 billion TTM revenue.

Where does Axon generate most of its revenue?

The majority of revenue comes from the United States through sales of TASER devices, body-worn cameras, and software subscriptions to police departments and other public safety agencies. International markets are expanding, but domestic public-sector contracts remain the primary driver, supported by 33.7% quarterly revenue growth.

What are Axon's main competitive advantages?

Axon benefits from deep integration between its hardware and cloud software ecosystem, creating high switching costs for customers, along with a dominant market position in conducted energy weapons and strong brand recognition. Its 6.91% profit margin and 88.7% institutional ownership reflect these moats, reinforced by continuous innovation in AI analytics.

What are the key risks for AXON investors?

Primary risks include regulatory changes affecting TASER usage, competition from alternative less-lethal technologies, and sensitivity to municipal budget cycles that could impact spending. The stock's high trailing P/E of 183.51 amplifies volatility, though diversification into software subscriptions helps mitigate some cyclical exposure.

What is the growth outlook for Axon Enterprise?

Analysts project continued double-digit revenue expansion driven by software subscriptions and international adoption, with a consensus price target of $662.04. Forward P/E of 55.25 suggests the market anticipates sustained earnings growth from the current $2.49 TTM EPS, supported by 89.8% recent quarterly earnings momentum.